SEC Form 4 · accession 0001209191-15-086474
Tracon Pharmaceuticals, Inc. · TCON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
CSA Biotechnology Fund I, llc
10% Owner
BROOKLINE TRACON INVESTMENT FUND LLC
10% Owner
CSA Biotechnology Fund II, LLC
10% Owner
Period of report
Jul 30, 2015
Accepted (ET)
Dec 21, 2015 · 8:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001394319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 30, 2015 | J | 416,059 | $0.00 | D | 241,493 | D | |
| Common Stock | Jul 30, 2015 | J | 437,210 | $0.00 | D | 0 | I | By Brookline Tracon Investment Fund, LLC |
| Common Stock | holding | — | — | — | 49,380 | I | By CSA Biotechnology Fund I, LLC | |
| Common Stock | holding | — | — | — | 93,460 | I | By CSA Biotechnology Fund II, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pro rata distribution of shares to the members of the limited liability company.